img

Global Prophylactic Hepatitis B Virus Vaccines Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Prophylactic Hepatitis B Virus Vaccines Market Research Report 2024

The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer.
According to MRAResearch’s new survey, global Prophylactic Hepatitis B Virus Vaccines market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prophylactic Hepatitis B Virus Vaccines market research.
The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth of prophylactic hepatitis B virus vaccines market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Prophylactic Hepatitis B Virus Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck
Sanofi Pasteur
Novartis
Pfizer
GlaxoSmithKline
Segment by Type
Hepatitis B
Liver Cirrhosis
Hepatocellular Carcinoma
Liver Failure

Segment by Application


Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Prophylactic Hepatitis B Virus Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Hepatitis B
1.2.3 Liver Cirrhosis
1.2.4 Hepatocellular Carcinoma
1.2.5 Liver Failure
1.3 Market by Application
1.3.1 Global Prophylactic Hepatitis B Virus Vaccines Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prophylactic Hepatitis B Virus Vaccines Market Perspective (2018-2033)
2.2 Prophylactic Hepatitis B Virus Vaccines Growth Trends by Region
2.2.1 Global Prophylactic Hepatitis B Virus Vaccines Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Prophylactic Hepatitis B Virus Vaccines Historic Market Size by Region (2018-2023)
2.2.3 Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Region (2024-2033)
2.3 Prophylactic Hepatitis B Virus Vaccines Market Dynamics
2.3.1 Prophylactic Hepatitis B Virus Vaccines Industry Trends
2.3.2 Prophylactic Hepatitis B Virus Vaccines Market Drivers
2.3.3 Prophylactic Hepatitis B Virus Vaccines Market Challenges
2.3.4 Prophylactic Hepatitis B Virus Vaccines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prophylactic Hepatitis B Virus Vaccines Players by Revenue
3.1.1 Global Top Prophylactic Hepatitis B Virus Vaccines Players by Revenue (2018-2023)
3.1.2 Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Players (2018-2023)
3.2 Global Prophylactic Hepatitis B Virus Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prophylactic Hepatitis B Virus Vaccines Revenue
3.4 Global Prophylactic Hepatitis B Virus Vaccines Market Concentration Ratio
3.4.1 Global Prophylactic Hepatitis B Virus Vaccines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prophylactic Hepatitis B Virus Vaccines Revenue in 2022
3.5 Prophylactic Hepatitis B Virus Vaccines Key Players Head office and Area Served
3.6 Key Players Prophylactic Hepatitis B Virus Vaccines Product Solution and Service
3.7 Date of Enter into Prophylactic Hepatitis B Virus Vaccines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prophylactic Hepatitis B Virus Vaccines Breakdown Data by Type
4.1 Global Prophylactic Hepatitis B Virus Vaccines Historic Market Size by Type (2018-2023)
4.2 Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Type (2024-2033)
5 Prophylactic Hepatitis B Virus Vaccines Breakdown Data by Application
5.1 Global Prophylactic Hepatitis B Virus Vaccines Historic Market Size by Application (2018-2023)
5.2 Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Prophylactic Hepatitis B Virus Vaccines Market Size (2018-2033)
6.2 North America Prophylactic Hepatitis B Virus Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2018-2023)
6.4 North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prophylactic Hepatitis B Virus Vaccines Market Size (2018-2033)
7.2 Europe Prophylactic Hepatitis B Virus Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2018-2023)
7.4 Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size (2018-2033)
8.2 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2018-2023)
8.4 Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size (2018-2033)
9.2 Latin America Prophylactic Hepatitis B Virus Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2018-2023)
9.4 Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size (2018-2033)
10.2 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2018-2023)
10.4 Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Detail
11.1.2 Merck Business Overview
11.1.3 Merck Prophylactic Hepatitis B Virus Vaccines Introduction
11.1.4 Merck Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023)
11.1.5 Merck Recent Development
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Company Detail
11.2.2 Sanofi Pasteur Business Overview
11.2.3 Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Introduction
11.2.4 Sanofi Pasteur Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023)
11.2.5 Sanofi Pasteur Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Prophylactic Hepatitis B Virus Vaccines Introduction
11.3.4 Novartis Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Prophylactic Hepatitis B Virus Vaccines Introduction
11.4.4 Pfizer Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Introduction
11.5.4 GlaxoSmithKline Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023)
11.5.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Hepatitis B
Table 3. Key Players of Liver Cirrhosis
Table 4. Key Players of Hepatocellular Carcinoma
Table 5. Key Players of Liver Failure
Table 6. Global Prophylactic Hepatitis B Virus Vaccines Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Region (2018-2023)
Table 10. Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Region (2024-2033)
Table 12. Prophylactic Hepatitis B Virus Vaccines Market Trends
Table 13. Prophylactic Hepatitis B Virus Vaccines Market Drivers
Table 14. Prophylactic Hepatitis B Virus Vaccines Market Challenges
Table 15. Prophylactic Hepatitis B Virus Vaccines Market Restraints
Table 16. Global Prophylactic Hepatitis B Virus Vaccines Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Players (2018-2023)
Table 18. Global Top Prophylactic Hepatitis B Virus Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prophylactic Hepatitis B Virus Vaccines as of 2022)
Table 19. Ranking of Global Top Prophylactic Hepatitis B Virus Vaccines Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Prophylactic Hepatitis B Virus Vaccines Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Prophylactic Hepatitis B Virus Vaccines Product Solution and Service
Table 23. Date of Enter into Prophylactic Hepatitis B Virus Vaccines Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Type (2018-2023)
Table 27. Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Type (2024-2033)
Table 29. Global Prophylactic Hepatitis B Virus Vaccines Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Application (2018-2023)
Table 31. Global Prophylactic Hepatitis B Virus Vaccines Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Prophylactic Hepatitis B Virus Vaccines Revenue Market Share by Application (2024-2033)
Table 33. North America Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size by Country (2024-2033) & (US$ Million)
Table 48. Merck Company Detail
Table 49. Merck Business Overview
Table 50. Merck Prophylactic Hepatitis B Virus Vaccines Product
Table 51. Merck Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023) & (US$ Million)
Table 52. Merck Recent Development
Table 53. Sanofi Pasteur Company Detail
Table 54. Sanofi Pasteur Business Overview
Table 55. Sanofi Pasteur Prophylactic Hepatitis B Virus Vaccines Product
Table 56. Sanofi Pasteur Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023) & (US$ Million)
Table 57. Sanofi Pasteur Recent Development
Table 58. Novartis Company Detail
Table 59. Novartis Business Overview
Table 60. Novartis Prophylactic Hepatitis B Virus Vaccines Product
Table 61. Novartis Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Pfizer Company Detail
Table 64. Pfizer Business Overview
Table 65. Pfizer Prophylactic Hepatitis B Virus Vaccines Product
Table 66. Pfizer Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. GlaxoSmithKline Company Detail
Table 69. GlaxoSmithKline Business Overview
Table 70. GlaxoSmithKline Prophylactic Hepatitis B Virus Vaccines Product
Table 71. GlaxoSmithKline Revenue in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023) & (US$ Million)
Table 72. GlaxoSmithKline Recent Development
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prophylactic Hepatitis B Virus Vaccines Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Type: 2022 VS 2033
Figure 3. Hepatitis B Features
Figure 4. Liver Cirrhosis Features
Figure 5. Hepatocellular Carcinoma Features
Figure 6. Liver Failure Features
Figure 7. Global Prophylactic Hepatitis B Virus Vaccines Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Application: 2022 VS 2033
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Prophylactic Hepatitis B Virus Vaccines Report Years Considered
Figure 12. Global Prophylactic Hepatitis B Virus Vaccines Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Prophylactic Hepatitis B Virus Vaccines Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Region: 2022 VS 2033
Figure 15. Global Prophylactic Hepatitis B Virus Vaccines Market Share by Players in 2022
Figure 16. Global Top Prophylactic Hepatitis B Virus Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prophylactic Hepatitis B Virus Vaccines as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Prophylactic Hepatitis B Virus Vaccines Revenue in 2022
Figure 18. North America Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2018-2033)
Figure 20. United States Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2018-2033)
Figure 24. Germany Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Prophylactic Hepatitis B Virus Vaccines Market Share by Region (2018-2033)
Figure 32. China Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2018-2033)
Figure 40. Mexico Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Prophylactic Hepatitis B Virus Vaccines Market Share by Country (2018-2033)
Figure 44. Turkey Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Prophylactic Hepatitis B Virus Vaccines Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Merck Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023)
Figure 47. Sanofi Pasteur Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023)
Figure 48. Novartis Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Prophylactic Hepatitis B Virus Vaccines Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed